MindBio Therapeutics Corp. (CSE:MBIO)
Canada
· Delayed Price · Currency is CAD 0.800
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 3.84 million as of March 9, 2026. Its market cap has increased by 42.08% in one year.
Market Cap
3.84M
Enterprise Value
5.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 3.84M, a decrease of -95.19%. That is a compound annual growth rate of -65.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.84M | -35.97% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XORTX Therapeutics | 4.18M |
| ASEP Medical Holdings | 3.34M |
| BioVaxys Technology | 4.63M |
| Rakovina Therapeutics | 3.17M |
| Gemina Laboratories | 3.06M |
| MYND Life Sciences | 5.22M |
| Aptose Biosciences | 5.51M |
| Appili Therapeutics | 2.65M |